Patents by Inventor Anette Schneemann

Anette Schneemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antitoxin and vaccine platform based on nodavirus VLPS
    Patent number: 8404247
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: March 26, 2013
    Assignees: The Salk Institute for Biological Studies, The Scripps Research Institute
    Inventors: John Young, Anette Schneemann, Marianne Manchester, Kelly Dryden, John M. Marlett, Darly Joseph Manayani, Godfrey Jonah Anderson Rainey, Vijay Reddy, Marc E. Siladi, Heather M. Scobie, Diane Thomas, Mark Yeager
  • Novel Antitoxin and Vaccine Platform Based on Nodavirus VLPS
    Publication number: 20120156237
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Application
    Filed: June 23, 2011
    Publication date: June 21, 2012
    Applicants: THE SCRIPPS RESEARCH INSTITUTE, THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
    Inventors: JOHN YOUNG, ANETTE SCHNEEMANN, MARIANNE MANCHESTER, KELLY DRYDEN, JOHN M. MARLETT, DARLY JOSEPH MANAYANI, GODFREY JONAH ANDERSON RAINEY, VIJAY REDDY, MARC E. SILADI, HEATHER M. SCOBIE, DIANE THOMAS, MARK YEAGER
  • Antitoxin and vaccine platform based on nodavirus VLPs
    Patent number: 7998487
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: August 16, 2011
    Assignees: The Salk Institute for Biological Studies, The Scripps Research Institute
    Inventors: John Young, Anette Schneemann, Marianne Manchester, Kelly Dryden, John M. Marlett, Darly Joseph Manayani, Godfrey Jonah Anderson Rainey, Vijay Reddy, Marc E. Siladi, Heather M. Scobie, Diane Thomas, Mark Yeager
  • Novel antitoxin and vaccine platform based on nodavirus VLPS
    Publication number: 20080299148
    Abstract: Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
    Type: Application
    Filed: February 14, 2008
    Publication date: December 4, 2008
    Applicants: The Salk Institute for Biological Studies, The Scripps Research Institute
    Inventors: John Young, Anette Schneemann, Marianne Manchester, Kelly Dryden, John M. Marlett, Darly Joseph Manayani, Godfrey Jonah Anderson Rainey, Vijay Reddy, Marc E. Siladi, Heather M. Scobie, Diane Thomas, Mark Yeager
  • Nodavirus-Vlp Immunization Composition
    Publication number: 20080286294
    Abstract: The present invention relates to an immunogenic composition for fish comprising nodavirus virus-like particles (VLPs) formed with nodavirus capsid protein assembly, for use as a vaccine. This composition is suitable for administration to fish via the intramuscular or intraperitoneal route, or by bath and/or via the oral route. The invention also relates to the use of such VPLs for the manufacturing of a vaccine for treating or preventing fish against a nodavirus infection. Fish farming baths and concentrates comprising the nodavirus VLP composition, as well as fish farming methods, are also encompassed in the present invention.
    Type: Application
    Filed: May 19, 2005
    Publication date: November 20, 2008
    Applicants: AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENT, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Richard Thiery, Marine Baud, Joelle Cabon, Joelle Cozien, Francois Lamour, Chan-Shing Lin, Neel Krishna, John E. Johnson, Anette Schneemann
  • Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
    Patent number: 6113905
    Abstract: The present invention presents: genomic nucleotide sequence of Borna disease virus, nucleotide and amino acid sequences of Borna disease virus proteins, recombinant viral proteins, vectors and cells containing the sequences or encoding the proteins, ligand binding to these proteins such as antibodies, and the diagnostic and therapeutic uses of the foregoing.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: September 5, 2000
    Assignee: The Regents of the University of California
    Inventors: W. Ian Lipkin, Thomas Briese, Stefanie Kliche, Patrick A. Schneider, Lothar Stitz, Anette Schneemann
  • Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
    Patent number: 6015660
    Abstract: The present invention presents: genomic nucleotide sequence of Borna disease virus, nucleotide and amino acid sequences of Borna disease virus proteins, recombinant viral proteins, vectors and cells containing the sequences or encoding the proteins, ligand binding to these proteins such as antibodies, and the diagnostic and therapeutic uses of the foregoing.
    Type: Grant
    Filed: January 6, 1995
    Date of Patent: January 18, 2000
    Assignee: The Regents of the University of California
    Inventors: W. Ian Lipkin, Thomas Briese, Stefanie Kliche, Patrick A. Schneider, Lothar Stitz, Anette Schneemann